4//SEC Filing
BEN-MAIMON CAROLE 4
Accession 0001062993-25-001078
CIK 0001374690other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:15 PM ET
Size
11.1 KB
Accession
0001062993-25-001078
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Award
Common Stock
2025-01-22+91,000→ 387,208 total - Award
Stock Option (Right to Buy)
2025-01-22+546,000→ 546,000 totalExercise: $3.46Exp: 2035-01-22→ Common Stock (546,000 underlying)
Holdings
- 12,249(indirect: By Trust)
Common Stock
- 12,249(indirect: By Trust)
Common Stock
- 12,248(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Meadow Lainey Ben-Maimon ("Meadow Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Meadow Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F3]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Olivia Liat Stein ("Olivia Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Olivia Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F4]Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Ella Bar Stein ("Ella Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Ella Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.
- [F5]The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.
Issuer
Larimar Therapeutics, Inc.
CIK 0001374690
Entity typeother
Related Parties
1- filerCIK 0001529611
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:15 PM ET
- Size
- 11.1 KB